THE GOALS AND OBJECTIVES OF THE WESTERN STATES GENETIC SERVICES COLLABORATIVE ARE:
GOAL 1: Maintain and strengthen existing partnerships among stakeholders in the Western States Genetic Services Collaborative (WSGSC) region while cultivating relevant new partnerships to improve individual and family health throughout the life course.
- Objective 1.1: Maintain the administrative infrastructure and provide regional leadership for the Collaborative.
- Objective 1.2: Ensure excellent communication among stakeholders and partners via in-person meetings, telephone calls, inter-active videoconferencing, webinars, social media, email, and the existing WSGSC website.
- Objective 1.3: Strengthen relationships with existing stakeholders including consumer advocates, state public health genomics and newborn screening leaders, genetic specialists, primary care providers, genomics researchers, and federal agencies to assure broad-based community involvement in Collaborative initiatives.
- Objective 1.4: Evaluate and identify the needs of potential new partners among insurers, allied health professionals, industry, government agencies, and academia to ensure inclusion of diverse and relevant stakeholders in Collaborative initiatives.
GOAL 2: Improve access to and reduce disparities in newborn screening and clinical genetic and genomic services, in the context of a patient-centered medical home, for individuals with or at risk for heritable disorders.
- Objective 2.1: Continue to model and evaluate use of innovative service delivery methods to improve access to newborn screening and clinical genetic and genomic services for individuals with or at risk for heritable and metabolic disorders, and congenital malformations.
- Objective 2.2: Develop and assess effective approaches for ensuring individuals who access and fully participate in newborn screening and clinical genetic and genomic services within a patient-centered medical home.
- Objective 2.3: Continue to improve third-party reimbursement of genetic and genomic services including counseling, management, treatment, and testing.
- Objective 2.4: Continue to develop and assess regional systems for newborn screening long-term follow-up by improving screening practices and developing, implementing, and evaluating use of evidence-based clinical guidelines.
GOAL 3: Increase the capacity of states’ and territory’s public health agencies to perform newborn screening, genetics, and genomics-related assessment, policy, and assurance functions.
- Objective 3.1: Continue to provide leadership in the western states to facilitate public health leaders’ access to expertise in newborn screening, genetics, and genomics relevant to public health core functions.
- Objective 3.2: Continue to disseminate, on a local, regional, and national level, findings from evaluation of innovations modeled in Collaborative initiatives.
- Objective 3.3: Based upon input from public health leaders and other stakeholders, create and disseminate newborn screening, genetics, and genomics educational products that may be used by public health agencies to improve knowledge and awareness of genomics within the western states population, including primary care and other healthcare providers.
GOAL 4: Assist Western States Genetic Services Collaborative stakeholders in translating emerging genomic information into their policies and practices.
- Objective 4.1: Identify relevant genomic information that is ready for translation into clinical services and public health.
- Objective 4.2: Disseminate existing or create new resources to aid target audiences to incorporate genomic knowledge in their policies and practices.